Curative Biosciences Inc (CBDX)
OTHER OTC:CBDX
US Market

Curative Biosciences (CBDX) Income Statement

6 Followers

Curative Biosciences Income Statement

Last quarter (Q ), Curative Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Curative Biosciences's net income was $-31.98K. See Curative Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 17Jun 16Jun 15Jun 14Jun 13
Total Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00$ 161.95K
Cost of Revenue
---$ 0.00$ 0.00$ 105.67K
Gross Profit
---$ 0.00$ 0.00$ 56.28K
Operating Expense
$ 518.10K$ 53.20K$ 1.66M$ 1.71M$ 468.66K$ 894.59K
Operating Income
$ -518.10K$ -53.20K$ -1.66M$ -1.71M$ -468.66K$ -838.30K
Net Non Operating Interest Income Expense
------
Other Income Expense
--$ -16.13K$ -1.66M$ -29.53M$ -5.80M
Pretax Income
$ -518.10K$ -53.20K$ -1.66M$ -3.37M$ -30.00M$ -6.64M
Tax Provision
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -518.10K$ -53.20K$ -1.66M$ -3.37M$ -30.00M$ -6.64M
Basic EPS
$ -0.03$ >-0.01$ -0.12$ -0.44$ -8.11$ -122.00
Diluted EPS
$ -0.03$ >-0.01$ -0.12$ -0.44$ -8.11$ -122.00
Basic Average Shares
$ 67.11M$ 15.71M$ 13.93M$ 7.63M$ 3.70M$ 54.20K
Diluted Average Shares
$ 67.11M$ 15.71M$ 13.93M$ 7.63M$ 3.70M$ 54.20K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 518.10K$ 53.20K$ 1.66M$ 1.71M$ 468.66K$ 1.00M
Net Income From Continuing And Discontinued Operation
$ -518.10K$ -53.20K$ -1.66M$ -3.37M$ -30.00M$ -6.64M
Normalized Income
$ -518.10K$ -53.20K$ -1.66M$ -1.71M$ -468.66K$ -838.30K
Interest Expense
------
EBIT
$ -518.10K$ -53.20K$ -1.66M$ -1.71M$ -468.66K$ -838.30K
EBITDA
$ -515.49K$ -50.35K$ -1.65M$ -1.70M$ -425.67K$ -772.22K
Currency in USD

Curative Biosciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis